Please login to the form below

Not currently logged in
Email:
Password:

Dr Jan van de Winkel joins Austrian biotech Hookipa

Joins the firm's board of directors, taking up the chairman's role

Dr Van De WinkelAustrian biotech Hookipa has appointed its chairman of the board of directors in the form of Dr Jan van de Winkel.

Current president and chief executive officer of Genmab, Dr van de Winkel joins the board with over 25 years’ experience in the therapeutic antibody field.

He said: “I am honoured to take on the role of chairman at this exciting time in the life of this very promising company and I am looking forward to building the company together with its management team and other board members who have done this very successfully before.”

Dr van de Winkel’s career experience has seen him serve Medarex Europe as its vice president and scientific director before co-founding Genmab.

Jorn Aldag, chief executive officer, Hookipa, said: “We are proud to have attracted Jan to join our board of directors as Chairman.

“As Hookipa grows and progresses to become an integrated biotech company with multiple clinical programmes in infectious diseases and immune-oncology, Jan’s experience of building companies and his scientific insight will prove invaluable.”

7th November 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Virgo Health

Virgo Health is an award-winning global healthcare communications and medical education agency comprising specialists with some of the best skills,...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics